MaryRose Cusimano Reaston, Ph.D.
Chief Executive Officer, Chief Scientific Officer and co-Founder
MaryRose Cusimano Reaston, Ph.D. is the Chief Executive Officer, Chief Scientific Officer and co-Founder of Emerge Diagnostics. She developed the Electrodiagnostic Functional Assessment (EFA), is a noted author on the technology, and serves as an expert witness in the field. Dr. Cusimano Reaston was awarded Risk & Insurance’s Risk Innovator of the Year for 2012, as well as a Liberty Mutual Responsibility Leader in Workers’ Compensation. She received her Ph.D. from Sierra College and her B.A. from University of California, Los Angeles.
Chief Technology Officer and co-Founder
Phil Reaston is the Chief Technology Officer and co-Founder of Emerge Diagnostics. Mr. Reaston is a certified IBM Architect and MQ Series Engineer, with an extensive background in information technology and computer programming. Previously, Mr. Reaston was chief technology officer of Insight Diagnostics, where was designed and implemented all front and back end systems. Prior to Insight Diagnostics, he was a consulting IT architect at IBM Global Services. Before joining IBM, he held several developer and management roles at CommerceQuest, Office Depot, Empire Stores, Woolworths, Avon & Bristol Computer Unit, Phoenix Assurance and IBM United Kingdom.
Chairman of the Board
Robert Thompson is Chairman of the Board of Emerge Diagnostics. Previously, he was the CEO of eScreen Inc., the largest provider of employment-related medical services in the country, including drug testing and pre-employment physicals. eScreen was sold in 2012 for $270 million to Alere. Prior to that, he was CEO of Orasure Technologies and CFO and COO of LabOne. Mr. Thompson has an MBA from Harvard and a BSE from Wharton School of Business at the University of Pennsylvania.